233 related articles for article (PubMed ID: 26617405)
1. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
[TBL] [Abstract][Full Text] [Related]
2. Post partial nephrectomy surveillance imaging: an evidence-based approach.
Marconi L; Gorin MA; Allaf ME
Curr Urol Rep; 2015 Apr; 16(4):23. PubMed ID: 25749808
[TBL] [Abstract][Full Text] [Related]
3. A review on follow-up strategies for renal cell carcinoma after nephrectomy.
Skolarikos A; Alivizatos G; Laguna P; de la Rosette J
Eur Urol; 2007 Jun; 51(6):1490-500; discussion 1501. PubMed ID: 17229521
[TBL] [Abstract][Full Text] [Related]
4. Follow-up after curative treatment of localised renal cell carcinoma.
Dabestani S; Marconi L; Kuusk T; Bex A
World J Urol; 2018 Dec; 36(12):1953-1959. PubMed ID: 29767327
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
[TBL] [Abstract][Full Text] [Related]
6. Is simple enucleation a minimal partial nephrectomy responding to the EAU guidelines' recommendations?
Ficarra V; Galfano A; Cavalleri S
Eur Urol; 2009 Jun; 55(6):1315-8. PubMed ID: 18801609
[No Abstract] [Full Text] [Related]
7. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
[TBL] [Abstract][Full Text] [Related]
8. Urological cancer: towards rational post-nephrectomy follow-up guidelines in RCC.
Patard JJ; Escudier B
Nat Rev Clin Oncol; 2015 Mar; 12(3):131-2. PubMed ID: 25668729
[No Abstract] [Full Text] [Related]
9. The future of nephron sparing procedures for renal masses: balancing costs, efficacy, patient outcomes and experience.
Lotan Y
J Urol; 2011 May; 185(5):1560-1. PubMed ID: 21419436
[No Abstract] [Full Text] [Related]
10. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
12. Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma.
Yu J; Zhang G; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Li QY; Mu MJ; Li X
Abdom Imaging; 2015 Oct; 40(8):3248-56. PubMed ID: 26288264
[TBL] [Abstract][Full Text] [Related]
13. Rebuttal from authors re: Vincenzo Ficarra, Antonio Galfano and Stefano Cavalleri. Is simple enucleation a minimal partial nephrectomy responding to the EAU guidelines' recommendations? Eur Urol 2009;55:1315-8.
Minervini A; Serni S; Di Cristofano C; Carini M
Eur Urol; 2009 Jun; 55(6):1319-20. PubMed ID: 18804906
[No Abstract] [Full Text] [Related]
14. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs.
Zargar-Shoshtari K; Kim T; Simon R; Lin HY; Yue B; Sharma P; Spiess PE; Poch MA; Pow Sang J; Sexton WJ
Urology; 2015 Aug; 86(2):321-6. PubMed ID: 26187013
[TBL] [Abstract][Full Text] [Related]
15. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
16. Surveillance following surgery for nonmetastatic renal cell carcinoma.
Richards KA; Abel EJ
Curr Opin Urol; 2016 Sep; 26(5):432-8. PubMed ID: 27467135
[TBL] [Abstract][Full Text] [Related]
17. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
18. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
19. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
20. Rationale for total nephrectomy for suspected renal cell carcinoma.
Marsh CL; Lange PH
Semin Urol Oncol; 1995 Nov; 13(4):273-80. PubMed ID: 8595551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
